Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0U2KX
|
|||
| Former ID |
DIB014971
|
|||
| Drug Name |
Aloradine
|
|||
| Indication | Glioma [ICD-11: 2A00.0; ICD-9: 191] | Phase 2 | [1] | |
| Company |
Pherin pharmaceuticals
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H28O
|
|||
| Canonical SMILES |
CC12CCC3C(C1CC=C2)CC=C4C3(CCC(C4)O)C
|
|||
| InChI |
1S/C19H28O/c1-18-9-3-4-16(18)15-6-5-13-12-14(20)7-11-19(13,2)17(15)8-10-18/h3,5,9,14-17,20H,4,6-8,10-12H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1
|
|||
| InChIKey |
QVHPTAJAHUONLV-DYKIIFRCSA-N
|
|||
| CAS Number |
CAS 1224-94-8
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Pherin Pharmaceuticals. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.